3 completed, 1 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
Follow aramchol: new trials by email Literature Review of aramchol trials Research Report on aramchol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy Aramchol, Placebo - Nonalcoholic Fatty Liver Disease, HIV | Phase 2 | Completed | University of California, San Diego | 50 | 2016-01-01 | 2020-07-17 |
| A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH Aramchol - Fatty Liver, Non-Alcoholic Steatohepatitis | Phase 2 | Completed | Galmed Research and Development, Ltd. | 247 | 2015-04-29 | 2021-07-14 |
| Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study Aramchol, Placebo, Ultrasound - Gallstones | Phase 2 | Terminated | Galmed Pharmaceuticals Ltd | 10 | 2014-10-01 | 2015-10-05 |
| Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis Aramchol, Placebo - Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis | Phase 2 | Completed | Galmed Medical Reserch | 60 | 2010-11-01 | 2012-01-31 |
Non-alcoholic Fatty Liver Disease (3) · Fatty Liver (2) · Diabetes Mellitus (1) · Fibrosis (1) · Gallstones (1) · Insulin Resistance (1) · Liver Cirrhosis (1) · Liver Diseases (1) · Metabolic Syndrome (1) · Obesity (1)
Galmed Medical Reserch (1) · Galmed Pharmaceuticals Ltd (1) · Galmed Research and Development, Ltd. (1) · University of California, San Diego (1)
Israel (3) · United States (2) · Chile (1) · France (1) · Georgia (1) · Germany (1) · Hong Kong (1) · Italy (1) · Lithuania (1) · Mexico (1) · Romania (1)
Asnat Raziel, MD (1) · Ran Oren, Doctor (1) · Rohit Loomba, M.D. (1) · Vlad Ratziu, MD, PhD (1)